Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hypokinesia

• An Open-Label Study of 50 mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women With Low Testosterone and HSDD
• A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With
• Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
• Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
• The Basel BOMP-AID Randomized Trial
• Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
• Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
• Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure
• Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
• Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
• Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men
• Treatment of Hypoactive Delirium and Outcome Measures
• 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
• 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
• Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder
• Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder
• Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder
• Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
• Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
• Safety Study of HPP593 in Subjects During and After Limb Immobilization
• Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
• Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
• Testosterone Patch's Effects on the Cardiovascular System and Libido
• Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder
• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
• Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
• Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients
• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
• Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity
• Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
• Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
• Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
• Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
• Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
• Testosterone in Female Hypoactive Sexual Desire Disorder